Prostaglandins Increase Trabecular Meshwork Outflow Facility in Cultured Human Anterior Segments

American Journal of Ophthalmology

Volumn 145, Issue 1, 2008, Pages 114-119

  Bahler, Cindy K ^a   Howell, Kyle G ^a   Hann, Cheryl R ^a   Fautsch, Michael P ^a   Johnson, Douglas H ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; LATANOPROST; PROSTAGLANDIN E1; STROMELYSIN;

ADULT; AGED; ANTERIOR EYE SEGMENT; ARTICLE; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; HYDRAULIC CONDUCTIVITY; IMMUNOHISTOCHEMISTRY; ORGAN CULTURE; PRIORITY JOURNAL; SCHLEMM CANAL; SCLERA; TRABECULAR MESHWORK; UVEA; WESTERN BLOTTING; ZYMOGRAPHY;

AGED; AGED, 80 AND OVER; ALPROSTADIL; ANTERIOR EYE SEGMENT; ANTIHYPERTENSIVE AGENTS; AQUEOUS HUMOR; BLOTTING, WESTERN; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MATRIX METALLOPROTEINASES; ORGAN CULTURE TECHNIQUES; PROSTAGLANDINS F, SYNTHETIC; SCLERA; TRABECULAR MESHWORK;

EID: 37249029889     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2007.09.001     Document Type: Article

References (27)

1. Weinreb R.N., Kashiwagi K., Kashiwagi F., Tsukahara S., and Lindsey J.D. Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells. Invest Ophthalmol Vis Sci 38 (1997) 2772-2780
2. Weinreb R.N., Lindsey J.D., Marchenko G., Marchenko N., Angert M., and Strongin A. Prostaglandin FP agonists alter metalloproteinase gene expression in sclera. Invest Ophthalmol Vis Sci 45 (2004) 4368-4377
3. Noecker R.S., Dirks M.S., Choplin N.T., Bernstein P., Batoosingh A.L., and Whitcup S.M. A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am J Ophthalmol 135 (2003) 55-63
4. Parrish R.K., Palmberg P., Sheu W.P., and XLT Study Group. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol 135 (2003) 688-703
5. Christiansen G.A., Nau C.B., McLaren J.W., and Johnson D.H. Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma. Ophthalmology 111 (2004) 1658-1662
6. Lim K.S., Nau C.B., O'Byrne M.M., et al. The mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects: a crossover study. Ophthalmology (2007) Forthcoming.
7. Ziai N., Dolan J.W., Kacere R.D., and Brubaker R.F. The effects on aqueous dynamics of PhXA41, a new prostaglandin F-2α analogue, after topical application in normal and ocular hypertensive human eyes. Arch Ophthalmol 111 (1993) 1351-1358
8. Brubaker R.F., Schoff E.O., Nau C.B., Carpenter S.P., Chen K., and VanDenburgh A.M. Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics. Am J Ophthalmol 131 (2001) 19-24
9. Fatt I., and Hedbys B.O. Flow of water through the sclera. Exp Eye Res 10 (1970) 243-249
10. Jackson T.L., Hussain A., Hodgetts A., et al. Human scleral hydraulic conductivity: Age-related changes, topographical variation, and potential scleral outflow facility. Invest Ophthalmol Vis Sci 47 (2006) 4942-4946
11. Kim J.W., Lindsey J.D., Wang N., and Weinreb R.N. Increased human scleral permeability with prostaglandin exposure. Invest Ophthalmol Vis Sci 42 (2001) 1514-1521
12. Johnson D.H., and Tschumper R.C. Human trabecular meshwork organ culture: a new method. Invest Ophthalmol Vis Sci 28 (1987) 945-953
13. Johnson D.H., and Tschumper R.C. The effect of organ culture on human trabecular meshwork. Exp Eye Res 49 (1989) 113-127
14. Sjoquist B., and Stjernschantz J. Ocular and systemic pharmacokinetics of latanoprost in humans. Surv Ophthalmol 47 (2002) S6-S12
15. Johnson D.H. The effect of cytochalasin D on outflow facility and the trabecular meshwork of the human eye in perfusion organ culture. Invest Ophthalmol Vis Sci 38 (1997) 2790-2799
16. Bulin C., Bode A.J.G., Weber A.A., Schror K., Levkau B., and Fischer J.W. Differential effects of vasodilatory prostaglandins on focal adhesions, cytoskeletal architecture, and migration in human aortic smooth muscle cells. Arteriosclerosis Thromb Vasc Biol 25 (2005) 84-89
17. Linden C., and Alm A. Latanoprost and physostigmine have mostly additive ocular hypotensive effects in human eyes. Arch Ophthalmol 115 (1997) 857-861
18. Lee P., Shao H., Xu L., and Qu C. The effect of prostaglandin F-2α on intraocular pressure in normotensive human subjects. Invest Ophthalmol Vis Sci 29 (1988) 1474-1477
19. Villumsen J., and Alm A. Prostaglandin F-2α-isopropylester eye drops: Effects in normal human eyes. Br J Ophthalmol 73 (1989) 419-426
20. Nilsson S.F.E., Drecoll E., Lutjen-Drecoll E., et al. The prostandoid EP2-receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey. Invest Ophthalmol Vis Sci 47 (2006) 4042-4049
21. Dijkstra B.G., Schneemann A., and Hoyng P.F. Flow after prostaglandin E1 is mediated by receptor-coupled adenylyl cyclase in human anterior segments. Invest Ophthalmol Vis Sci 40 (1999) 2622-2626
22. Oh D.J., Martin J.L., Williams A.J., Russell P., Birk D.E., and Rhee D.J. Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 47 (2006) 3887-3895
23. Thieme H., Schimmat C., Munzer G., et al. Endothelin antagonism: effects of FP receptor agonists prostaglandin F-2α and fluporstenol on trabecular meshwork contractility. Invest Ophthalmol Vis Sci 47 (2006) 938-945
24. Bahler C.K., Hann C.R., Fautsch M.P., and Johnson D.H. Pharmacologic disruption of Schlemm's canal cells and outflow facility in anterior segments of human eyes. Invest Ophthalmol Vis Sci 45 (2004) 2246-2254
25. Richter M., Krauss A.H., Woodward D.F., and Lutjen-Drecoll E. Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide. Invest Ophthalmol Vis Sci 44 (2003) 4419-4426
26. Kim J.W., Lindsey J.D., Wang N., and Weinreb R.N. Increased human scleral permeability with prostaglandin exposure. Invest Ophthalmol Vis Sci 42 (2001) 1514-1521
27. Lindsey J.D., Crowston J.G., Tran A., Morris C., and Weinreb R.N. Direct matrix metalloproteinase enhancement of transscleral permeability. Invest Ophthalmol Vis Sci 48 (2007) 752-755